Q&A with Professor Ali Tavassoli of Curve Therapeutics: RSC Interdisciplinary Prize winner 2025
Description
On the latest episode of the Optimum Perspectives podcast, Optimum Strategic Communications’ Managing Director Eva Haas spoke with Curve Therapeutics CSO and Co-Founder Ali Tavassoli, who has today been awarded the Royal Society of Chemistry’s Interdisciplinary Prize.
Listen below as Ali reflects on his scientific journey which has led him to this tremendous recognition, from what inspired his passion for science, to how he came to meet Curve CEO Simon Kerry, with whom he co-founded the Company. Curve’s is using its revolutionary gene-encoded Microcycle® platform to build a pipeline of innovative cyclic peptide and small molecule drugs addressing intracellular targets, with a focus on cancer, immunology and inflammation.
Hosted on Acast. See acast.com/privacy for more information.
United States
